Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free GCAN Stock Alerts

Greater Cannabis (GCAN) Competitors

Greater Cannabis logo
$0.18 0.00 (0.00%)
As of 05/1/2026 09:30 AM Eastern
Compare

GCAN vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying Greater Cannabis stock or one of its competitors? The main competitors of Greater Cannabis include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does Greater Cannabis compare to Ainos?

Greater Cannabis (NASDAQ:GCAN) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Greater CannabisN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greater CannabisN/AN/AN/AN/AN/A
Ainos$124.16KN/AN/AN/AN/A

In the previous week, Greater Cannabis' average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Greater Cannabis Neutral
Ainos Neutral

Summary

Ainos beats Greater Cannabis on 1 of the 1 factors compared between the two stocks.

How does Greater Cannabis compare to Alvotech?

Greater Cannabis (NASDAQ:GCAN) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, risk, institutional ownership and dividends.

Company Net Margins Return on Equity Return on Assets
Greater CannabisN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greater CannabisN/AN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

In the previous week, Greater Cannabis' average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Greater Cannabis Neutral
Alvotech Neutral

Summary

Alvotech beats Greater Cannabis on 1 of the 1 factors compared between the two stocks.

How does Greater Cannabis compare to Aravive?

Greater Cannabis (NASDAQ:GCAN) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, risk, institutional ownership and dividends.

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Greater CannabisN/A N/A N/A
Aravive N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greater CannabisN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

In the previous week, Greater Cannabis' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
Greater Cannabis Neutral
Aravive Neutral

Summary

Aravive beats Greater Cannabis on 2 of the 2 factors compared between the two stocks.

How does Greater Cannabis compare to Atlantic Coastal Acquisition Corp. II?

Greater Cannabis (NASDAQ:GCAN) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, risk, institutional ownership and dividends.

In the previous week, Greater Cannabis' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Greater Cannabis Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Company Net Margins Return on Equity Return on Assets
Greater CannabisN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greater CannabisN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Summary

Greater Cannabis and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does Greater Cannabis compare to Avidity Biosciences?

Avidity Biosciences (NASDAQ:RNA) and Greater Cannabis (NASDAQ:GCAN) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

In the previous week, Avidity Biosciences had 1 more articles in the media than Greater Cannabis. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for Greater Cannabis. Avidity Biosciences' average media sentiment score of 0.00 equaled Greater Cannabis'average media sentiment score.

Company Overall Sentiment
Avidity Biosciences Neutral
Greater Cannabis Neutral

Avidity Biosciences presently has a consensus target price of $69.42, indicating a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher possible upside, research analysts plainly believe Avidity Biosciences is more favorable than Greater Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32
Greater Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Greater Cannabis has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Greater Cannabis' return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Avidity Biosciences-3,650.39% -44.92% -39.57%
Greater Cannabis N/A N/A N/A

Greater Cannabis has lower revenue, but higher earnings than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A
Greater CannabisN/AN/AN/AN/AN/A

Summary

Avidity Biosciences beats Greater Cannabis on 6 of the 9 factors compared between the two stocks.

Get Greater Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for GCAN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GCAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GCAN vs. The Competition

Export
MetricGreater CannabisDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.62B$6.25B$11.77B
Dividend YieldN/A2.97%2.74%5.26%
P/E RatioN/A4.1829.2527.07
Price / SalesN/A1,488.53504.6873.47
Price / CashN/A10.3743.3053.90
Price / BookN/A10.729.676.69
Net IncomeN/A$21.15B$3.55B$332.64M
7 Day Performance8.41%-1.16%1.70%2.01%
1 Month Performance3.47%0.17%5.62%9.19%
1 Year PerformanceN/A24.19%34.42%39.59%

Greater Cannabis Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GCAN
Greater Cannabis
N/A$0.18
flat		N/AN/A$0.00N/AN/A1
AIMDW
Ainos
N/A$0.09
+79.3%		N/AN/A$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.26
flat		N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GCAN) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel